RAS Antagonists and beta blockers stabilize HbA1c and improve insulin resistance in patients with diabetes free from cardiac disease

26 May 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: HF-DACH Poster session - Diabetes and the Heart Diabetes and the Heart HFA Premium Access Heart Failure 2018

ESC 365 is supported by

ESC 365 is supported by